🔎 Trials Near Me

Dachaigh › Ro-throm › North Carolina › Wilmington

Sgrùdaidhean clionaigeach Ro-throm ann an Wilmington, NC

Tha aon sgrùdadh airson Ro-throm a’ lorg phàirtichean aig làrach ann no faisg air Wilmington. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

A’ fastadhÌre 2
  • Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07752979

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

A’ fastadhÌre 3
  • Accellacare - Wilmington, Wilmington
  • Jeffrey Coleman, OD, Wilmington
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07595549

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

A’ fastadhÌre 2
  • TMA Headlands, Wilmington
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

A’ fastadhÌre 3
  • Trial Management Associates - Wilmington - Floral Parkway, Wilmington
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07794579

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

A’ fastadhÌre 3
  • Accellacare and KDCILM, LLC, Wilmington
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07720271

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

A’ fastadhÌre 3
  • Accellacare - Wilmington - 1917 Tradd Court, Wilmington
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

A’ fastadhÌre 3
  • Trial Management Associates - Wilmington - Floral Parkway, Wilmington
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07282600

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

A’ fastadhÌre 3
  • KDCILM, LLC & Accellacare US, Inc., Wilmington
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07745504

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

A’ fastadhÌre 3
  • Accellacare Research of Wilmington, Wilmington
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

A’ fastadhÌre 3
  • ACCOMPLISH-1 Research Site, Wilmington
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

A’ fastadhÌre 1
  • Accellacare, Wilmington
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT07607587

Sgrùdaidhean Ro-throm ann am bailtean eile

Sgrùdaidhean eile ann an Wilmington

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.